Impact of right-to-left shunt and transcatheter closure on the clinical features of migraine

References

• Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci. 2017;372:307–315.
   PubMed Web of Science ®Google Scholar
• Burstein R, Noseda R, Borsook D. Migraine: multiple processes, complex pathophysiology. J Neurosci. 2015;35(17):6619–6629.
   PubMed Web of Science ®Google Scholar
• Wang SJ, Fuh JL, Juang KD, et al. Migraine and suicidal ideation in adolescents aged 13 to 15 years. Neurology. 2009;72(13):1146–1152.
   PubMed Web of Science ®Google Scholar
• Boran HE, Bolay H. Pathophysiology of Migraine. NoroPsikiyatrArs. Noro Psikiyatr Ars. 2013;50(Suppl 1):S1–S7.
   PubMedGoogle Scholar
• Souteyrand G, Motreff P, Lusson JR, et al. Comparison of transthoracic echocardiography using second harmonic imaging, transcranial Doppler and transesophageal echocardiography for the detection of patent foramen ovale in stroke patients. Eur J Echocardiogr. 2006;7(2):147–154. Mar
   PubMed Web of Science ®Google Scholar
• Domitrz I, Styczynski G, Wilczko J, et al. An association between migraines and heart anomalies-true or false? A heart ultrasound study using cTTE in migraine patients and control participants. Pain Med. 2014;15(12):2156–2160.
   PubMed Web of Science ®Google Scholar
• Del Sette M, Angeli S, Leandri M, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis. 1998;8(6):327–330.
   PubMed Web of Science ®Google Scholar
• Reisman M, Christofferson RD, Jesurum J, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol. 2005;45(4):493–495.
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.
   PubMed Web of Science ®Google Scholar
• Xing YQ, Guo YZ, Gao YS, et al. Effectiveness and safety of transcatheter patent foramen ovale closure for migraine (EASTFORM). Sci Rep. 2016;6:39081.
   PubMed Web of Science ®Google Scholar
• Stewart WF, Lipton RB, Kolodner K, et al. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia. 1999;19(2):107–114.
   PubMed Web of Science ®Google Scholar
• Sauro KM, Rose MS, Becker WJ, et al. HIT-6 and MIDAS as measures of headache disability in a headache referral population. Headache. 2010;50(3):383–395.
   PubMed Web of Science ®Google Scholar
• Hao N, Liu K, Guo ZN, et al. Comparison of two contrast agents for right-to-left shunt diagnosis with contrast-enhanced transcranial Doppler. Ultrasound Med Biol. 2014;40(9):2317–2320.
   PubMed Web of Science ®Google Scholar
• Ramachandran R. Neurogenic inflammation and its role in migraine. Semin Immunopathol. 2018;40(3):301–314.
   Google Scholar
• Domitrz I, Mieszkowski J, Kwieciński H. The prevalence of patent foramen ovale in patients with migraine. Neurol Neurochir Pol. 2004;38(2):89–92.
   PubMedGoogle Scholar
• Dalla Volta G, Guindani M, Zavarise P, et al. Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain. 2005;6(4):328–330. Sep
   PubMedGoogle Scholar
• Wilmshurst P, Nightingale S. The role of cardiac and pulmonary pathology in migraine: a hypothesis. Headache. 2006;46(3):429–434.
   PubMed Web of Science ®Google Scholar
• Rohrhoff N, Vavalle JP, Halim S, et al. Current status of percutaneous PFO closure. Curr Cardiol Rep. 2014;16(5):477.
   PubMed Web of Science ®Google Scholar
• Schwedt TJ, Demaerschalk BM, Dodick DW. Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia. 2008;28(5):531–540.
   PubMed Web of Science ®Google Scholar
• van Gent MW, Mager JJ, Snijder RJ, et al. Relation between migraine and size of echocardiographic intrapulmonary right-to-left shunt. Am J Cardiol. 2011;107(9):1399–1404.
   PubMed Web of Science ®Google Scholar
• Seiler C. Patent foramen ovale (PFO): is there life before death in the presence of PFO?. Eur J Clin Invest. 2015;45(8):875–882.
   PubMed Web of Science ®Google Scholar
• Kahya Eren N, Bülbül NG, Yakar Tülüce S, et al. To be or not to be patent: the relationship between migraine and patent foramen ovale. Headache. 2015;55(7):934–942.
   PubMed Web of Science ®Google Scholar
• Sharma A, Gheewala N, Silver P. Role of patent foramen ovale in migraine etiology and treatment: a review. Echocardiography. 2011;28(8):913–917.
   PubMed Web of Science ®Google Scholar
• Wang SB, Liu KD, Yang Y, et al. Prevalence and extent of right-to-left shunt on contrast-enhanced transcranial Doppler in Chinese patients with migraine in a multicentre case-control study. Cephalalgia. 2018;38(4):690–696.
   PubMed Web of Science ®Google Scholar
• Schwedt TJ, Dodick DW. Patent foramen ovale and migraine-bringing closure to the subject. Headache. 2006;46(4):663–671.
   PubMed Web of Science ®Google Scholar
• Davis D, Gregson J, Willeit P, et al. Patent foramen ovale, ischemic stroke and migraine: systematic review and stratified meta-analysis of association studies. Neuroepidemiology. 2013;40(1):56–67.
   PubMed Web of Science ®Google Scholar
• Tariq N, Tepper SJ, Kriegler JS. Patent foramen ovale and migraine: closing the debate – a review. Headache. 2016;56(3):462–478.
   PubMed Web of Science ®Google Scholar
• Rigatelli G, Dell'Avvocata F, Ronco F, et al. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism. JACC Cardiovasc Interv. 2010;3(3):282–287.
   PubMed Web of Science ®Google Scholar
• Khessali H, Mojadidi MK, Gevorgyan R, et al. The effect of patent foramen ovale closure on visual aura without headache or typical aura with migraine headache. JACC Cardiovasc Interv. 2012;5(6):682–687.
   PubMed Web of Science ®Google Scholar
• Mortelmans K, Post M, Thijs V, et al. The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J. 2005;26(15):1533–1537.
   PubMed Web of Science ®Google Scholar
• Shi YJ, Lv J, Han XT, et al. Migraine and percutaneous patent foramen ovale closure: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2017;17(1):203.
   PubMed Web of Science ®Google Scholar